HSP90B1 and neoplasm: More so, it has been recently shown that tumor-derived gp96 can induce protection against lymphocytic choriomeningitis virus (LCMV) infection and against tumors, thereby emphasizing that gp96 fits in the “one for all” vaccine category [79,80].